<?xml version="1.0" encoding="UTF-8"?>
<p id="Par40">Significant vaccine efficacy against new infections after treatment for 14 HR-HPV infection was observed. The nonsignificant effect against new infections associated with HPV-16/18 and cervical lesions (LSIL+ and CIN2+) maybe caused by the limited power with smaller number of women. However, the vaccine may still benefit post-treatment women with the "primary prophylactic‚Äù effect. Further research is required in clarifying the effect of using the prophylactic HPV vaccine as therapeutic agents.</p>
